"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et ...

Our bone builder, EVENITY, also delivered in 2024, with sales increasing 35% year-over-year. Despite its strong growth trajectory, the large majority of patients at high risk for fracture from ...

A new report from the NC Department of Health and Human Services on the programs around the state reveals that most counties have such programs – ones that give out clean syringes and other drug ...

Property News: This area has clocked the biggest annual boom in internal migration of any area in Australia. © 2025 Nine Entertainment Co.

Editor’s note: Every Friday, “Weekend Plug-in” meets readers at the intersection of faith and news. Click to join nearly 10,000 subscribers who get this column delivered straight to their inbox. Got ...

Amgen Inc. (NASDAQ:AMGN) Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations were $5.04. Operator: My name is Julienne ...

UCB and Amgen’s osteoporosis drug Evenity has finally been approved in Europe, following a successful appeal against a regulatory rejection, to become the first new drug for the condition since ...